InvestorsHub Logo
Followers 0
Posts 21
Boards Moderated 0
Alias Born 03/07/2017

Re: None

Thursday, 03/23/2017 11:35:33 AM

Thursday, March 23, 2017 11:35:33 AM

Post# of 9818
I like the aggressive tone of this! proactive!
Bringing Vitel under our umbrella gives us a formidable network and international presence that opens the door to a litany of possibilities towards meeting our goals. Our mid-term plan is continuing to build shareholder value through the clinical development of ProscaVax in the U.S. and Mexico, maintaining an aggressive position on growing our revenue streams through licensing/acquisition of additional drugs for the international markets and positioning us to seek qualification for an listing on a national stock exchange."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent THER News